ZKIN
ZK International Group Co., Ltd.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Mar 26 ZK International Group's shareholders approved the sale of multiple…
- R Aug 21 ZK International's 6-K filing for H1 FY2026 reveals a company in a s…
- X Aug 31 Short interest jumps 60.9% to 37.5K
- X Sep 15 Short interest falls 54.5% to 17.1K
- X Sep 30 Short interest jumps 152.0% to 43.0K
- X Oct 15 Short interest falls 31.9% to 29.2K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
- Short sellersCOVERING
Short interest −31.9% to 29.2K shares. 3.4 days to cover, ≈0.1% of shares.
- TrendUPTREND
2% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $1.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
3 filings · 0 bullish · 2 bearish · 1 neutral- BEARISH 6-KAug 21, 2026
ZK International's 6-K filing for H1 FY2026 reveals a company in a severe financial crisis: it…
This filing confirms ZKIN is a distressed shell with no viable operating business, minimal cash, and highly speculative assets. The stock is a high-risk binary event: either the AWA tokens or AI…
- BEARISH 6-KMar 26, 2026
ZK International Group's shareholders approved the sale of multiple subsidiaries to Pioneer…
Traders should assess whether the $21M proceeds represent full value for the divested operations, particularly given ZKIN's $29M market cap. The company may be left with minimal ongoing operations…
- NEUTRAL EFFECTMar 12, 2026
ZK International Group's Form F-3 shelf registration has become effective, allowing the company to…
Monitor for future 424B prospectus supplements or 8-K filings that may disclose actual offerings, pricing, and use of proceeds. The shelf registration increases financing flexibility but introduces…
All ZKIN filing & press-release reports (3)
- 6-K reportAug 21, 2026
- 6-K reportMar 26, 2026
- EFFECT reportMar 12, 2026